FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
2,253 letters match. Newest first.
-
DrugsNewman Clinic, PLLC dba Newman Clinic
FDA told Newman Clinic its website misbranded compounded semaglutide and tirzepatide with false and misleading claims.
Medium -
DrugsNewSelf Limited dba NewSelf
FDA warns NewSelf over misleading website claims for compounded semaglutide and tirzepatide, including false compounder and FDA-approval implications.
Low -
Drugs24HrDoc, Inc. dba 24HrDoc
FDA says 24HrDoc's website misbrands compounded semaglutide and tirzepatide with false claims that it compounds them and that they match Ozempic, Wegovy, Mounjaro, Zepbound.
Medium -
DrugsAlan Health Technologies Inc. dba Alan
FDA warns Alan Health Technologies over website falsely labeling compounded semaglutide and tirzepatide as Alan-made.
Low -
DrugsDripgym Mobile Parent, LLC dba Amp Health
FDA warned Amp Health that its website misbranded compounded semaglutide and tirzepatide with false maker and approval-implying claims.
Low -
DrugsBelle Health LLC dba Belle
FDA warned Belle Health that its website falsely suggests Belle compounds semaglutide and tirzepatide, making the drugs misbranded.
Low -
DrugsBliv Wellness LLC dba Bliv
FDA warns Bliv Wellness that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.
Medium -
DrugsBluefitMD
FDA warned BluefitMD that its website falsely labels compounded semaglutide and tirzepatide as its own and as FDA-approved.
Low -
DrugsDeluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics
FDA warned Deluxe IV and Aesthetics over misleading website claims for compounded semaglutide and tirzepatide, including implying FDA approval.
Low -
DrugsAspen Aesthetics dba Fifty 410
FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.
Low -
DrugsFitRX, LLC dba FitRx
FitRx's website misbranded compounded semaglutide and tirzepatide with false and misleading claims, FDA says.
Medium -
DrugsGenesis Health International Inc. dba Genesis
FDA warns Genesis over misleading website claims for compounded semaglutide and tirzepatide.
Low -
DevicesDiasol, Inc.
Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.
High risk -
TobaccoThe Sabagh Group Inc/lighterusa.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccoswedishproducts.online
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
BiologicsDynamic Stem Cell Therapy
FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.
High risk -
DevicesExThera Medical Corporation
ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.
High risk -
DevicesBeta Bionics, Inc.
FDA says Beta Bionics' iLet Bionic Pancreas system had quality-system failures, including ignored complaints of severe hypoglycemia and diabetic ketoacidosis.
High risk -
TobaccoTombak LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsMedisourceRx
MedisourceRx failed to report a serious adverse event and had inadequate procedures, so its compounded drugs lost legal exemptions.
Medium -
AnimalElanco Animal Health USA
FDA says Elanco's Pradalex ads misbrand the livestock antibiotic by claiming first-line use and "all relevant pathogen" coverage.
Medium -
BiologicsProDx Health
FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.
High risk -
Tobacconiqpouches.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoBNC Distribution Inc.
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccogotpouches.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodCC Pollen Company
FDA warns CC Pollen Company of Glendale, Arizona, that its bee pollen and royal jelly supplements are adulterated and misbranded.
High risk -
FoodEniva USA, Inc.
FDA warns Eniva USA over manufacturing quality failures for Immune Support and Ashwagandha Gummies.
Medium -
BiologicsGermaphobix
FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.
High risk -
DrugsProdrome Sciences USA, LLC
Prodrome Sciences studied its supplement ProdromeNeuro Oil as a dementia drug in 29 people without first filing an IND, FDA says.
High risk -
BiologicsGenetrace
FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.
High risk -
BiologicsGenovate
FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.
High risk -
FoodLXR Biotech, LLC
FDA warns LXR Biotech over CGMP (manufacturing quality rules) failures for Eternal Energy supplements, making them adulterated (legally unfit as made).
Medium -
DevicesASP Global, LLC. dba Anatomy Supply Partners, LLC.
FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.
High risk -
FoodPan-African Food Distributors Inc./East Africa Boutique LLC
FDA found widespread rodent and insect infestation in Pan-African Food Distributors’ warehouse holding dietary supplements, foods and cosmetics.
High risk -
Tobaccosnuzyn.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccobongsociety.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsAgebox Inc.
Agebox Inc. sells iKids-Growth children's supplements containing the undeclared, unapproved drug ibutamoren, making them unapproved and misbranded drugs.
High risk -
DrugsPrivate Label Skin Care, Inc.
FDA warned Private Label Skin Care about poor quality oversight, continued sale of impurity-affected over-the-counter drugs, and missing drug listings.
High risk -
Tobaccosmokespotvape.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsDarmerica, LLC
FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.
High risk -
DevicesTG Supply LLC d/b/a TransGuy Supply
FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.
Low -
DevicesFlux Lab Pte. Ltd. d/b/a The Fluxion
FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.
Medium -
DevicesMarli Washington Design, LLC
Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.
Low -
DevicesFLAVNT Streetwear, LLC
FDA says FLAVNT Streetwear sold breast binders as medical devices without registering or listing them for fiscal 2026.
Low -
DevicesEarly to Bed, Inc.
FDA warned Early to Bed, Inc. that its breast binders are misbranded because the manufacturer was not registered or listed with FDA.
Low -
DevicesGenderBender LLC
GenderBender LLC sells breast binders as medical devices without FDA registration or listing, making them misbranded.
Low -
DevicesTomboyX, PBC
FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.
Medium -
DevicesPhiladelphia 7, Inc d/b/a Passional Boutique
FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.
Low -
DevicesTOMSCOUT
FDA says TOMSCOUT sells breast binders as medical devices without required FDA registration or listing.
Low -
DevicesFor Them, Inc.
FDA says For Them, Inc. sells breast binders as unregistered medical devices, making them misbranded.
Low